Vimarsana
Biggest News Aggregation in the World

Keith Rodvold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keith Rodvold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keith Rodvold Today - Breaking & Trending Today

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update - Vimarsana News

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update

Published: November 13, 2023

Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO trial of tebipenem HBr; Trial expected to begin with First Patient, First Visit in 4Q 2023 Conference call and webcast at 4:30pm ET...

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomSath ShuklaLora GrassilliKeith RodvoldKevin WinthropJonb BrussAnkit MahadeviaTed JenkinsEsther RajaveluSatyavrat Sath ShuklaDepartment Of The ArmyOffice Of TheIntravenous Administration To Healthy AdultHealth Media RelationsWarfighter Medical Research Program Under Award NoAdministration For Strategic PreparednessSpero Therapeutics IncDepartment Of HealthHealth AffairsDevelopment AuthorityTebipenem Hbr ResearchDrug AdministrationZeno GroupGlobenewswire Inc
Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and ... - Vimarsana News

Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and ...

Published: April 21, 2022

CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced two oral presentations and four poster presentations at the 32nd European Congress of Clinical Microbiology

Source: kulr8.com
Related Topics:
United StatesUnited KingdomJacqueline Pomfret KirbyKeith RodvoldTsegaye SewunetPharmd University Of Illinois ChicagoTebipenem Hbr Research SupportPhd Karolinska InstituteSpero Therapeutics IncEuropean CongressBiomedical Advanced ResearchHuman ServicesUs Department Of HealthDrug AdministrationDevelopment AuthorityProgram CommitteeExchange CommissionOffice Of TheCorporate AffairsClinical MicrobiologyInfectious DiseasesPresenting AuthorIllinois ChicagoKarolinska InstituteKey Publications